Keyphrases
Volumetric muscle Loss
100%
Schwann Cells
50%
Human muscle
50%
Physical Activity
50%
Muscle Metabolism
50%
Local muscles
50%
Whole-body
50%
Neuromuscular Junction
42%
Formoterol
33%
Innervation
21%
Functional Deficits
19%
Whole-body Metabolism
12%
Skeletal muscle
12%
Regeneration
11%
Adult Male
11%
Metabolic
8%
Muscle Function
8%
Injury Model
8%
Skeletal muscle Function
8%
Oxidative Treatment
8%
Respiratory Exchange Ratio
8%
Lipid Peroxidation
8%
Physical Activity Restriction
8%
Muscle Mass
8%
Neurotrophic Factors
7%
Signaling Molecules
7%
Neurodegenerative Disease Model
7%
Lewis Rats
7%
Muscle Damage
7%
Denervation
7%
Secondary Losses
7%
Maladaptive Responses
7%
Morphological Characteristics
7%
Spontaneous Excitatory Postsynaptic Current (sEPSC)
7%
Junction Structure
7%
Collagen
7%
Overaccumulation
7%
Neuregulin-1 (NRG1)
7%
Inflammatory Pathways
7%
Tibialis Anterior muscle
7%
Dysregulation
7%
Neurotrophic Activity
7%
Nervous System
7%
Outcome Assessment
7%
Neurotrophin Signaling
7%
Skeletal muscle Injury
7%
Rodent Models
7%
Temporal Design
7%
Medicine and Dentistry
Injury
100%
Muscle Metabolism
50%
Physical Activity
50%
Schwann Cell
50%
Formoterol
44%
Skeletal Muscle
32%
Neuromuscular Junction
30%
Muscle Function
22%
Innervation
15%
Lipid Oxidation
11%
Lung Gas Exchange
11%
Muscle Injury
10%
Sympathomimetic Drug
5%
Functional Status
5%
Receptor
5%
Enzyme Activity
5%
Metabolomics
5%
Metabolic Rate
5%
Protein Expression
5%
Musculoskeletal Injury
5%
Biochemical Analysis
5%
Mitochondrial Enzyme
5%
Contractile Function
5%
Hindlimb
5%
Physical Inactivity
5%
Rehabilitation Engineering
5%
Outcome Assessment
5%
Tibialis Anterior Muscle
5%
Signaling Protein
5%
Disease Model
5%
Denervation
5%
Brain Derived Neurotrophic Factor
5%
Degenerative Disease
5%
Morphological Trait
5%
Neurotrophic Factor
5%
Nervous System
5%
Neuroscience
Schwann Cell
50%
Formoterol
50%
Neuromuscular Junction
50%
Metabolic Pathway
50%
Skeletal Muscle
39%
Innervation
25%
Lung Gas Exchange
12%
Neurotrophic Factor
8%
Nervous System
8%
Denervation
8%
Brain-Derived Neurotrophic Factor
8%
Neurodegenerative Disorder
8%
Receptor Agonists
6%
In Vivo
6%
Protein Expression
6%
Enzyme Activity
6%
Mitochondrial Enzyme
6%
Sympathomimetic Drug
6%
